We confirmed that the upregulation of p21 mRNA observed in the RNA-seq analysis corresponded to increased p21 protein expression in PGCC derived from PPC1 prostate cancer cells (Fig. 4A). This evidence concerns the gene CDKN1A and prostate carcinoma.